Income Statement

AQUESTIVE THERAPEUTICS, INC.

AQST
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY
Revenue
44.55 57.56 50.58 47.68 50.83 45.85 52.61 67.43
Cost of Revenue
18.56 17.87 20.83 - - 12.96 - -
Gross Profit
25.99 39.69 29.75 47.68 50.83 32.89 52.61 67.43
Operating Expenses
97.04 70.46 44.85 89.75 85.51 75.78 105.28 116.36
Research & Development
17.19 20.28 13.10 17.48 17.05 19.89 20.57 23.11
Selling, General & Administrative
79.85 50.18 31.75 52.88 53.48 55.89 64.34 72.26
Other Operating Expenses
- - - - - - - -
Operating Income
-71.05 -30.77 -15.10 -42.07 -34.68 -42.89 -52.67 -48.93
Non-Operating Income
12.73 13.38 -7.48 12.34 35.86 12.89 13.58 12.44
Interest Income
- - - - - 0.13 - -
Interest Expense
- - 6.34 6.55 10.05 11.06 9.32 7.71
Other Non-Op Income / Expense
-12.73 -13.38 - - - - - -
Income Before Tax
-83.78 -44.15 -7.63 -54.41 -70.54 -55.78 -66.25 -61.38
Income Tax Expense
0.00 -0.01 0.25 0.00 0.00 0.00 0.00 -61.38
Non-Controlling Interest
- - - - - - - -
Net Income
-83.78 -44.14 -7.87 -54.41 -70.54 -55.78 -66.25 0.00
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY Dec 31, 2018 2018 FY
Depreciation & Amortization
- - - - - - - -
EBITDA
-70.50 -30.05 -13.76 -39.68 -31.72 -39.45 -49.76 -45.75
Earnings Per Share (Basic)
-0.78 -0.51 -0.13 -1.12 -1.85 - - -
Diluted EPS
-0.78 -0.51 -0.13 -1.12 -1.85 - - -
Weighted Average Shares
106.93 86.73 61.26 48.73 38.08 - - -
Diluted Weighted Avg Shares
106.93 86.73 61.26 48.73 38.08 - - -
Comprehensive Income
-83.78 -44.14 -7.87 -54.41 -70.54 -55.78 -66.25 -61.38